February 4, 2019. We support USPSTF’s draft recommendation on hepatitis B virus infection screening in all pregnant women.
Read More »We’re Speaking Out on Health Issues
NCHR scientists and health policy experts provide written and oral statements on a wide range of topics.
Here are many of the ways we have been Speaking Out on Health Policy Issues for the last few years. Whether the topic is legislation intended to cure diseases, proposed bans on BPA or other chemicals that disrupt your hormones, the importance of including women, people of color, and patients over 65 in clinical trials, or many other topics, you’ll gain a better understanding of our evidence-based analyses by reading these letters, statements, and testimony.
Here are the ways we have been Speaking out on Medical Treatments and Products, such as prescription drugs and medical devices that the FDA is considering approving, or is considering taking off the market because of serious risks. Whether the topic is Chantix, Addyi, Yaz, Essure, or medical products you’ve never heard of, you can find out more about what is known and not known about the safety and effectiveness of a wide range of products by looking through this section of our website.
NCHR Comments on USPSTF’s Draft Research Plan for Colorectal Cancer: Screening
January 30, 2019. We strongly support the USPSTF’s efforts to update recommendations for different types of colorectal cancer screening for different demographic subgroups, as well as their broader efforts to improve the health of all Americans by making evidence-based recommendations about clinical preventive services.
Read More »Prepared Statement to the Greenwich Board of Estimate and Taxation Regarding Dangers of Artificial Turf, January 24, 2019
January 24, 2019. NCHR President Dr. Diana Zuckerman presented comments in Greenwich, CT regarding the possibility of artificial turf being used in their schools and fields.
Read More »NCHR Letter to Senators Regarding the Impact of the Government Shutdown on Patient Safety
January 11, 2019. NCHR authored a letter to senators regarding the effects of the government shutdown on the FDA and, therefore, patient safety.
Read More »


